News
Reversible posterior leukoencephalopathy syndrome is a disorder with characteristic radiologic findings that mainly involve the white and/or gray matter of the parieto-occipital lobes. Initially ...
5. Kleinschmidt-DeMasters, BK, Tyler, KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005;353: ...
The disease, acute toxic progressive leukoencephalopathy, deteriorates the brain due to toxin inhalation. Jacob's prognosis was grim; he would soon lose his mobility and speech.
Jacob Haendel, 32, has been recovering from both acute toxic progressive leukoencephalopathy (TAPL) and locked-in syndrome since 2018, documenting the process online.
Did you know that certain medications can cause symptom of 'Progressive multifocal leukoencephalopathy'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.
Use of a genetic risk test for patients considering immunosuppressive therapies associated with development of progressive multifocal leukoencephalopathy may help reduce incidence of disease ...
"Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation," McGinn recites. She prefers to call it, "awesome disease," though.
Progressive multifocal leukoencephalopathy (PML) was reported to have developed in three patients treated with natalizumab. We conducted an evaluation to determine whether PML had developed in any ...
Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is a rare, autosomal dominant white‐matter encephalopathy primarily associated with mutations in the colony stimulating factor 1 ...
Reversible posterior leukoencephalopathy syndrome (RPL) is characterized by white matter edema predominantly in the posterior parietal, temporal and occipital regions of the brain with ...
Reversible posterior leukoencephalopathy syndrome related to hypertension might be due to sudden elevation of blood pressure causing disruption of the autoregulatory mechanisms of the central ...
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab in Breast Cancer Authors: Francesco Sclafani [email protected], Gullo Giuseppe, Janusz Mezynksi, Conor Collins, and John Crown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results